FDA-Approved Brand-Name GLP-1s
GLP-1 Medications We Prescribe
Mounjaro, Zepbound, Wegovy, and Ozempic, the four most-effective GLP-1 medications, prescribed directly from our clinic at up to 75% less than retail pharmacy prices. Brand-name only, never compounded.
Most patients start at $275/mo. Some starting options are as low as $149/mo. Final pricing is set with your provider during your consultation.
Mounjaro®
Tirzepatide · Eli Lilly
Mounjaro® (tirzepatide) is a revolutionary dual-action medication that targets both GIP and GLP-1 receptors for powerful weight loss and blood sugar management.
Zepbound®
Tirzepatide · Eli Lilly
Zepbound® (tirzepatide) is FDA-approved specifically for chronic weight management—the same powerful dual-action medication as Mounjaro, now with official weight loss approval.
Wegovy®
Semaglutide · Novo Nordisk
Wegovy® (semaglutide) is FDA-approved for chronic weight management—the same medication as Ozempic at higher doses optimized specifically for weight loss.
Ozempic®
Semaglutide · Novo Nordisk
Ozempic® (semaglutide) is FDA-approved for type 2 diabetes and widely prescribed for weight loss. The medication that sparked the GLP-1 weight loss revolution.
Not sure which medication is right for you?
Final medication recommendations are made individually during your initial consultation, when your provider reviews your goals, history, and contraindications.